RICERCA
AUTORI
RIVISTE
Sfoglia per AUTORE
PINTO C
Collezione AOU Città della Salute di Torino
Items : 19
Impact of edoxaban-related adverse events in patients with cancer experiencing venous thromboembolism during antineoplastic therapy: Results of the phase IV EDOI study (GOIRC-05-2018). in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2025 Mar 26;219:115296. doi: 10.1016/j.ejca.2025.115296. Epub 2025 Feb 9.
2025
AOU Città della Salute di Torino
Maglietta G; Damato A; Finotto S; Mandarà M; Tamberi S; Grisanti S; Brighenti M; Tiseo M; Montesarchio V; Catino A; Gelsomino F; Giovanardi F; Antonuzzo L; Romagnani A; Gervasi E; Di Maio M; Pinto C;
Withdrawal notice to
2024
AO Ordine Mauriziano
AOU Città della Salute di Torino
Cavanna L; Cinieri S; Blasi L; Pinto C; Beretta GD; Piccirillo MC; Sferrazza A; Di Segni S; Olimpieri PP; Salerno F; Canciello A; Caglio A; Arenare L; Tomassini L; Celant S; Iacovino ML; Di Maio M; Russo P; Perrone F;
Comparison of baseline patient characteristics in Italian oncology drug monitoring registries and clinical trials: a real-world cross-sectional study. in The Lancet regional health. Europe / Lancet Reg Health Eur. 2024 Apr 22;41:100912. doi: 10.1016/j.lanepe.2024.100912. eCollection 2024 Ju
2024
AO Ordine Mauriziano
AOU Città della Salute di Torino
Russo P; Di Maio M; Cavanna L; Cinieri S; Blasi L; Pinto C; Beretta GD; Sferrazza A; Piccirillo MC; Di Segni S; Olimpieri PP; Salerno F; Canciello A; Arenare L; Caglio A; Tomassini L; Celant S; Iacovino ML; Perrone F;
Corrigendum to "Comparison of baseline patient characteristics in Italian oncology drug monitoring registries and clinical trials: a real-world cross-sectional study" [The Lancet Regional Health - Europe 41 (2024) 100912]. in The Lancet regional health. Europe / Lancet Reg Health Eur. 2024 Jun 24;42:100973. doi: 10.1016/j.lanepe.2024.100973. eCollection 2024 Ju
2024
AO Ordine Mauriziano
AOU Città della Salute di Torino
Cavanna L; Cinieri S; Blasi L; Pinto C; Domenico Beretta G; Piccirillo MC; Sferrazza A; Di Segni S; Olimpieri PP; Salerno F; Canciello A; Caglio A; Arenare L; Tomassini L; Celant S; Iacovino ML; Di Maio M; Russo P; Perrone F;
Corrigendum to "Comparison of baseline patient characteristics in Italian oncology drug monitoring registries and clinical trials: a real-world cross-sectional study" [The Lancet Regional Health - Europe 41 (2024) 100912]. in The Lancet regional health. Europe / Lancet Reg Health Eur. 2024 May 21;42:100940. doi: 10.1016/j.lanepe.2024.100940. eCollection 2024 Ju
2024
AO Ordine Mauriziano
AOU Città della Salute di Torino
Cavanna L; Cinieri S; Blasi L; Pinto C; Beretta GD; Piccirillo MC; Sferrazza A; Di Segni S; Olimpieri PP; Salerno F; Canciello A; Caglio A; Arenare L; Tomassini L; Celant S; Iacovino ML; Di Maio M; Russo P; Perrone F;
Breast-cancer specific comprehensive archive of Patient-Reported Outcome Measures (PROMs) for clinical research and clinical practice in oncology: Results from the PRO4All project. in Breast (Edinburgh, Scotland) / Breast. 2024 Dec;78:103817. doi: 10.1016/j.breast.2024.103817. Epub 2024 Sep 28.
2024
AOU Città della Salute di Torino
Valsecchi AA; Giovanardi F; Malandrini F; Meregaglia M; Servetto A; Bennati C; Pinto C; Di Maio M; Ciani O;
The development of an archive of patient-reported outcome measures (PROMs) in oncology: The Italian PRO4All project. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2024 Aug;207:114161. doi: 10.1016/j.ejca.2024.114161. Epub 2024 Jun 10.
2024
AOU Città della Salute di Torino
Malandrini F; Meregaglia M; Di Maio M; Pinto C; De Lorenzo F; Ciani O;
The role of nanoliposomal irinotecan plus fluorouracil/leucovorin in the continuum of care of patients with metastatic pancreatic ductal adenocarcinoma. in Cancer medicine / Cancer Med. 2023 Jul;12(13):14337-14345. doi: 10.1002/cam4.6111. Epub 2023 Jun 6.
2023
AO Ordine Mauriziano
AOU Città della Salute di Torino
Casalino S; Spadi R; Zaniboni A; Scartozzi M; Antonuzzo L; Milella M; De Vita F; Barsotti G; Zecchetto C; Pinto C; Zichi C; Giordano G; Satolli MA; Noventa S; Pretta A; Giommoni E; Vaccaro V; Fasano M; Merz V; Procaccio L; Bergamo F; De Toni C; Melisi D; Lonardi S;
Opioid-Induced Constipation in Real-World Practice: A Physician Survey, 1 Year Later. in Pain and therapy / Pain Ther. 2022 Jun;11(2):477-491. doi: 10.1007/s40122-022-00354-4. Epub 2022 Feb 5.
2022
AOU Città della Salute di Torino
Pinto C; Massazza G; Marinangeli F; Lugoboni F; Gianni W; Coluzzi F; Alvaro D; Varrassi G;
Effectiveness of a Psychosocial Care Quality Improvement Strategy to Address Quality of Life in Patients With Cancer: The HuCare2 Stepped-Wedge Cluster Randomized Trial. in JAMA network open / JAMA Netw Open. 2021 Oct 1;4(10):e2128667. doi: 10.1001/jamanetworkopen.2021.28667.
2021
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
Diodati F; Zerilli F; Sarobba G; Russo A; Procopio G; Pazzola A; Novello S; Mattioli R; Gori S; Giordani P; Cinieri S; Caputo F; Aragona M; Airoldi M; Pinto C; Verusio C; Annunziata MA; Caminiti C; Iezzi E; Maglietta G; Passalacqua R;
Common Clinical Practice for Opioid-Induced Constipation: A Physician Survey. in Journal of pain research / J Pain Res. 2021 Jul 24;14:2255-2264. doi: 10.2147/JPR.S318564. eCollection 2021.
2021
AOU Città della Salute di Torino
Varrassi G; Pinto C; Massazza G; Marinangeli F; Gianni W; Caraceni AT; Alvaro D; Coluzzi F; Lugoboni F;
An integrated care pathway for cancer patients with diabetes: A proposal from the Italian experience. in Diabetes research and clinical practice / Diabetes Res Clin Pract. 2020 Jan;159:107721. doi: 10.1016/j.diabres.2019.04.036. Epub 2019 May 11.
2020
AOU Città della Salute di Torino
Russo A; Musacchio N; Candido R; Chantal Ponziani M; Farci D; Suraci C; Michelini M; Cristiano Corsi D; Clemente G; Gallo M; Pinto C; Mannino D; Gori S;
What to Do and What Not to Do in the Management of Opioid-Induced Constipation: A Choosing Wisely Report. in Pain and therapy / Pain Ther. 2020 Dec;9(2):657-667. doi: 10.1007/s40122-020-00195-z. Epub 2020 Sep 17.
2020
AOU Città della Salute di Torino
Pinto C; Marinangeli F; Massazza G; Lugoboni F; Gianni W; Coluzzi F; Caraceni AT; Alvaro D; Varrassi G;
Correction to: What to Do and What Not to Do in the Management of Opioid-Induced Constipation: A Choosing Wisely Report. in Pain and therapy / Pain Ther. 2020 Dec;9(2):669-670. doi: 10.1007/s40122-020-00204-1.
2020
AOU Città della Salute di Torino
Alvaro D; Caraceni AT; Coluzzi F; Gianni W; Lugoboni F; Marinangeli F; Massazza G; Pinto C; Varrassi G;
Quality of life, compliance, safety and effectiveness in fit older metastatic colorectal patients with cancer treated in first-line with chemotherapy plus cetuximab: A restrospective analysis from the ObservEr study. in Journal of geriatric oncology / J Geriatr Oncol. 2018 May;9(3):243-248. doi: 10.1016/j.jgo.2018.01.009. Epub 2018 Feb 9.
2018
AOU Città della Salute di Torino
Rosati G; Pinto C; Di Fabio F; Chiara S; Lolli IR; Ruggeri EM; Ciuffreda L; Ferrara R; Antonuzzo L; Adua D; Racca P; Bilancia D; Benincasa E; Stroppolo ME; Di Costanzo F;
Phase II Study of Preoperative Treatment with External Radiotherapy Plus Panitumumab in Low-Risk, Locally Advanced Rectal Cancer (RaP Study/STAR-03). in The oncologist / Oncologist. 2018 Aug;23(8):912-918. doi: 10.1634/theoncologist.2017-0484. Epub 2018 Mar 9.
2018
AOU Città della Salute di Torino
Damato A; Ciardiello F; Frassineti L; Bustreo S; Bergamo F; Marino A; Aschele C; Rosati G; Cordio S; Latiano T; Bochicchio A; Di Fabio F; Di Bisceglie M; Pinto C; Giaquinta S; Baldari D; Boni L; Pinto C; Di Bisceglie M; Di Fabio F; Bochicchio A; Latiano T; Cordio S; Rosati G; Aschele C; Marino A; Bergamo F; Bustreo S; Frassineti L; et alii...
Observational study on quality of life, safety, and effectiveness of first-line cetuximab plus chemotherapy in KRAS wild-type metastatic colorectal cancer patients: the ObservEr Study. in Cancer medicine / Cancer Med. 2016 Nov;5(11):3272-3281. doi: 10.1002/cam4.888. Epub 2016 Oct 17.
2016
AOU Città della Salute di Torino
Pinto C; Di Fabio F; Rosati G; Lolli IR; Ruggeri EM; Ciuffreda L; Ferrari D; Lo Re G; Rosti G; Tralongo P; Ferrara R; Alabiso O; Chiara S; Ianniello GP; Frassoldati A; Bilancia D; Campanella GA; Signorelli C; Racca P; Benincasa E; Stroppolo ME; Di Costanzo F;
Acute skin toxicity management in head and neck cancer patients treated with radiotherapy and chemotherapy or EGFR inhibitors: Literature review and consensus. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2015 Oct;96(1):167-82. doi: 10.1016/j.critrevonc.2015.06.001. Epub 2015 Jul
2015
AOU Città della Salute di Torino
Russi EG; Moretto F; Rampino M; Benasso M; Bacigalupo A; De Sanctis V; Numico G; Bossi P; Buglione M; Lombardo A; Airoldi M; Merlano MC; Licitra L; Denaro N; Pergolizzi S; Pinto C; Bensadoun RJ; Girolomoni G; Langendijk JA;
Assessment of a HER2 scoring system for colorectal cancer: results from a validation study. in Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc / Mod Pathol. 2015 Nov;28(11):1481-91. doi: 10.1038/modpathol.2015.98. Epub 2015 Oct 9.
2015
AOU Città della Salute di Torino
Valtorta E; Martino C; Sartore-Bianchi A; Penaullt-Llorca F; Viale G; Risio M; Rugge M; Grigioni W; Bencardino K; Lonardi S; Zagonel V; Leone F; Noe J; Ciardiello F; Pinto C; Labianca R; Mosconi S; Graiff C; Aprile G; Frau B; Garufi C; Loupakis F; Racca P; Tonini G; Lauricella C; Veronese S; Truini M; Siena S; Marsoni S; et alii...